Squarepoint’s Contineum Therapeutics CTNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$355K Sell
89,414
-41,613
-32% -$165K ﹤0.01% 2082
2025
Q1
$915K Sell
131,027
-86,212
-40% -$602K ﹤0.01% 1567
2024
Q4
$3.18M Sell
217,239
-132,761
-38% -$1.94M ﹤0.01% 964
2024
Q3
$6.7M Buy
350,000
+200,000
+133% +$3.83M 0.01% 630
2024
Q2
$2.64M Buy
+150,000
New +$2.64M ﹤0.01% 945